Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Phys Rev Lett ; 125(2): 021301, 2020 Jul 10.
Article in English | MEDLINE | ID: mdl-32701326

ABSTRACT

On January 14, 2019, the Major Atmospheric Gamma Imaging Cherenkov telescopes detected GRB 190114C above 0.2 TeV, recording the most energetic photons ever observed from a gamma-ray burst. We use this unique observation to probe an energy dependence of the speed of light in vacuo for photons as predicted by several quantum gravity models. Based on a set of assumptions on the possible intrinsic spectral and temporal evolution, we obtain competitive lower limits on the quadratic leading order of speed of light modification.

2.
Eur Rev Med Pharmacol Sci ; 21(21): 4935-4940, 2017 Nov.
Article in English | MEDLINE | ID: mdl-29164565

ABSTRACT

OBJECTIVE: Curcumin is one of the most investigated phytochemical products because of its low toxicity and its broad spectrum of bioactivity, including anti-inflammatory and analgesic properties. A new delivery form of curcumin, resorting to phosphatidylcholine (Meriva®, formulated as the finished product Algocur®) has been developed to increase its bioavailability. In this study, we tested the efficacy and safety of a Meriva®-based product in rugby players suffering by different osteo-muscular pain conditions PATIENTS AND METHODS: In this pilot study, 50 male rugby players with osteo-muscular pain due to traumatic injuries, physical overload or acute episode of chronic pain were recruited and treated with conventional analgesic drugs (n = 25) or Meriva®-based product (n = 25) for a maximum of 10 days. The pain perception and the functio laesa were evaluated at baseline and after 1, 3, 6, 10 and 20 days from the initiation of the treatment protocol. Treatment tolerability, compliance, and adverse events were also reported. RESULTS: During the study, the analgesic effect decreased in both treated group compared to baseline, starting from the third day of treatment. Similarly, the impaired physical function evaluated after 3, 6, 10 and 20 days improved in Meriva®-based product treated group and in subjects treated with conventional analgesic drugs, compared to the baseline condition. The percentage of excellent adherence to treatment or tolerability was higher in the Meriva®-based product treated group. Only 1 (4%) subject treated with Meriva®-based product experienced adverse events whereas 4 (16%) subjects treated with conventional analgesic drugs reported gastric pain as an adverse event. CONCLUSIONS: Despite the small sample size and the group heterogeneity, this study suggests that the naturally-derived, curcumin-based delivery form, Meriva® (formulated as the finished product Algocur®), could represent a promising safe, analgesic remedy in painful osteo-muscular conditions associated with intense, high impact, physical activities.


Subject(s)
Curcumin/chemistry , Lecithins/therapeutic use , Pain/drug therapy , Adult , Analgesics/therapeutic use , Athletes , Drug Compounding , Humans , Lecithins/chemistry , Male , Medication Adherence , Muscular Diseases , Pilot Projects , Young Adult
3.
Eur Rev Med Pharmacol Sci ; 20(21): 4601-4606, 2016 11.
Article in English | MEDLINE | ID: mdl-27874935

ABSTRACT

OBJECTIVE: Streptococcus salivarius K12 (BLIS K12) is a probiotic strain strongly antagonistic to the growth of Streptococcus pyogenes, the most important bacterial cause of pharyngeal infections in humans. Shown to colonize the oral cavity and to be safe for human use, BLIS K12 has previously been reported to reduce pharyngo-tonsillitis episodes in children or adults known to have experienced recurrent streptococcal infection. The present study was focussed upon evaluating the role of BLIS K12 in the control of streptococcal disease and acute otitis media in children attending the first year of kindergarten. PATIENTS AND METHODS: By randomization, 222 enrolled children attending the first year of kindergarten were divided into a treated group (N = 111) receiving for 6 months a daily treatment with BLIS K12 (Bactoblis®) and a control group (N = 111) who were monitored as untreated controls. During the 6 months of treatment and 3 months of follow-up, the children were evaluated for treatment tolerance, and for episodes of streptococcal pharyngo-tonsillitis, scarlet fever and acute otitis media. RESULTS: During the 6-month trial (N = 111 per group) the incidence of streptococcal pharyngo-tonsillitis, scarlet fever and acute otitis media was approximately 16%, 9% and 44% respectively in the treated group and 48%, 4% and 80% in the control group. During the 3-months follow-up (N = 29 per group) the corresponding rates of infection were 15%, 0% and 12% in the treated group and 26%, 6% and 36% in the controls. No apparent side effects were detected in the treated group either during treatment or follow-up. All of the enrolled children completed the study. CONCLUSIONS: The daily administration of BLIS K12 to children attending their first year of kindergarten was associated with a significant reduction in episodes of streptococcal pharyngitis and acute otitis media. No protection against scarlet fever was detected.


Subject(s)
Otitis Media/prevention & control , Probiotics/administration & dosage , Streptococcal Infections/prevention & control , Case-Control Studies , Child, Preschool , Female , Humans , Male , Otitis Media/microbiology , Pharyngitis/microbiology , Pharyngitis/prevention & control , Scarlet Fever/microbiology , Scarlet Fever/prevention & control , Streptococcal Infections/microbiology , Streptococcus pyogenes/pathogenicity , Streptococcus salivarius , Tonsillitis/microbiology , Tonsillitis/prevention & control
4.
Eur Rev Med Pharmacol Sci ; 19(21): 4195-202, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26592847

ABSTRACT

OBJECTIVE: This randomized, controlled study aims to evaluate the tolerability and the efficacy of curcumin in overweight subjects affected from metabolic syndrome, with a focus on impaired glucose intolerance and android-type fat accumulation. PATIENTS AND METHODS: Forty-four subjects, selected among those who after 30 days of diet and intervention lifestyle have shown a weight loss < 2%, have been treated for further 30 days either with curcumin complexed with phosphatidylserine in phytosome form or with pure phosphatidylserine. Outcomes concerning anthropometric measurements and body composition were analyzed at enrollment and after 30 and 60 days. RESULTS: Curcumin administration increased weight loss from 1.88 to 4.91%, enhanced percentage reduction of body fat (from 0.70 to 8.43%), increased waistline reduction (from 2.36 to 4.14%), improved hip circumference reduction from 0.74 to 2.51% and enhanced reduction of BMI (from 2.10 to 6.43%) (p < 0.01 for all comparisons). Phosphatidylserine did not show any statistical significant effect. Tolerability was very good for both treatments, and no drop-out was reported. CONCLUSIONS: Although preliminary, our findings suggest that a bioavailable form of curcumin is well-tolerated and can positively influence weight management in overweight people.


Subject(s)
Adipose Tissue/metabolism , Curcumin/metabolism , Metabolic Syndrome/metabolism , Overweight/metabolism , Weight Loss/physiology , Adipose Tissue/drug effects , Aged , Biological Availability , Body Composition/drug effects , Body Composition/physiology , Body Mass Index , Curcumin/administration & dosage , Dietary Supplements , Feeding Behavior/physiology , Female , Humans , Male , Metabolic Syndrome/diet therapy , Metabolic Syndrome/epidemiology , Middle Aged , Overweight/diet therapy , Overweight/epidemiology , Risk Reduction Behavior , Weight Loss/drug effects
5.
Eur Rev Med Pharmacol Sci ; 19(19): 3757-62, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26502867

ABSTRACT

OBJECTIVE: The combination of inhaled corticosteroids (ICS) and long-acting beta-agonists (LABAs) is recommended for the treatment of patients with mild-to-severe persistent asthma. However, given the lack of definite and safe therapies, complementary or alternative medicines are frequently used by asthmatic patients in combination with standard treatments. PATIENTS AND METHODS: A group of asthmatic subjects have been enrolled in this multicenter study; after having verified the compliance to their current medical therapy (ICS + LABAs), the subjects have been randomized to receive Casperome® 500 mg/day or no additional treatment for a period of 4 weeks. They were also asked to keep track of the number of inhalations required per day and any adverse events through a daily form. RESULTS: A total of 32 subjects were enrolled in the study. Subjects receiving Casperome® 500 mg/day in addition to the standard ICS + LABAs treatment showed a decrease in the number of inhalations needed compared to patients who did not receive Casperome® therapy. The treatment was well tolerated and only mild-moderate adverse events were registered. CONCLUSIONS: The use of Casperome® 500 mg/day is beneficial for asthmatic patients as it helps reduce the need for inhalation therapy with ICS + LABA.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Adrenergic beta-Agonists/therapeutic use , Anti-Asthmatic Agents/therapeutic use , Asthma/drug therapy , Boswellia/chemistry , Drug Therapy, Combination/methods , Administration, Inhalation , Adolescent , Adrenal Cortex Hormones/administration & dosage , Adult , Aged , Aged, 80 and over , Complementary Therapies , Female , Humans , Male , Middle Aged , Patient Compliance , Young Adult
6.
Eur Rev Med Pharmacol Sci ; 19(8): 1338-44, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25967706

ABSTRACT

OBJECTIVE: Acute radiation erythema and other skin reactions are common adverse effects experienced by breast carcinoma patients undergoing radiotherapy treatment. Boswellic acids are pentacyclic triterpenes extracted from the resins of the tropical tree Boswellia serrata with strong anti-inflammatory properties. This study was designed to evaluate the safety and the efficacy of the application of a base cream containing boswellic acids in a proprietary formulation (Bosexil(R)) for the prevention and relief of radiation-induced adverse effects in breast cancer patients. PATIENTS AND METHODS: The acute skin reactions were clinically evaluated by visual intensity and computer-assisted skin color analysis, and toxicity was assessed by the Radiation Therapy Oncology Group (RTOG) rating scale. RESULTS: These findings indicate that the use of a boswellia-based cream is effective in reducing the use of topical corticosteroids and is able to reduce the grade of erythema and the skin superficial symptoms, being well tolerated by the patients. CONCLUSIONS: Further studies comparing boswellia cream with other topical agents will be appropriate to confirm the effectiveness of this treatment for breast cancer patients under radiation therapy.


Subject(s)
Boswellia , Breast Neoplasms/radiotherapy , Radiodermatitis/prevention & control , Radiotherapy, Adjuvant/adverse effects , Skin Cream/administration & dosage , Triterpenes/administration & dosage , Adult , Aged , Breast Neoplasms/diagnosis , Female , Humans , Middle Aged , Plant Extracts/administration & dosage , Plant Extracts/adverse effects , Radiodermatitis/diagnosis , Skin Cream/adverse effects , Treatment Outcome , Triterpenes/adverse effects
8.
Phys Rev Lett ; 113(22): 221101, 2014 Nov 28.
Article in English | MEDLINE | ID: mdl-25494064

ABSTRACT

We report the first direct measurement of the overall characteristics of microwave radio emission from extensive air showers. Using a trigger provided by the KASCADE-Grande air shower array, the signals of the microwave antennas of the Cosmic-Ray Observation via Microwave Emission experiment have been read out and searched for signatures of radio emission by high-energy air showers in the GHz frequency range. Microwave signals have been detected for more than 30 showers with energies above 3×10^{16} eV. The observations presented in this Letter are consistent with a mainly forward-directed and polarized emission process in the GHz frequency range. The measurements show that microwave radiation offers a new means of studying air showers at E≥10^{17} eV.

9.
G Ital Dermatol Venereol ; 148(5): 479-83, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24005140

ABSTRACT

In patients affected by psoriasis, use of a topical formula containing a derivative of zebrafish embryos was associated with reduced skin inflammation and dermal turnover, as well as a generally better outcome. In an attempt to understand the molecular mechanisms lying beyond these findings, we investigated the anti-proliferative effects of the zebrafish embryos derivative by addressing the mitochondrial function (MTT assay) and cell nuclei distribution (Hoestch staining). In cell cultures stimulated with fetal calf serum (FCS) or epidermal growth factor (EGF), the zebrafish derivative significantly inhibited cell proliferation induced by either approach, although the effect was stronger in cells stimulated with FCS. These results suggest that the zebrafish embryos derivative may dampen increased cell proliferation; this observation may be relevant to cutaneous pathologies related to altered proliferative mechanisms, including psoriasis.


Subject(s)
Keratinocytes/drug effects , Psoriasis/drug therapy , Tissue Extracts/pharmacology , Zebrafish/embryology , Animals , Cattle , Cell Nucleus/drug effects , Cell Survival/drug effects , Cells, Cultured/drug effects , Culture Media/pharmacology , Drug Evaluation, Preclinical , Epidermal Growth Factor/pharmacology , Fetal Blood , Humans , In Vitro Techniques , Keratinocytes/ultrastructure , Mitochondria/drug effects
10.
Phys Rev Lett ; 107(17): 171104, 2011 Oct 21.
Article in English | MEDLINE | ID: mdl-22107501

ABSTRACT

We report the observation of a steepening in the cosmic ray energy spectrum of heavy primary particles at about 8×10(16) eV. This structure is also seen in the all-particle energy spectrum, but is less significant. Whereas the "knee" of the cosmic ray spectrum at 3-5×10(15) eV was assigned to light primary masses by the KASCADE experiment, the new structure found by the KASCADE-Grande experiment is caused by heavy primaries. The result is obtained by independent measurements of the charged particle and muon components of the secondary particles of extensive air showers in the primary energy range of 10(16) to 10(18) eV. The data are analyzed on a single-event basis taking into account also the correlation of the two observables.

11.
Water Sci Technol ; 54(6-7): 57-64, 2006.
Article in English | MEDLINE | ID: mdl-17120634

ABSTRACT

The calibration of storm water runoff models is a complex task. Early attempts focused on the choice of a performance criterion function that could capture all the facets of the problem into a single-objective framework. Subsequently, the awareness that a good calibration must necessarily take into account conflicting objectives led to the adoption of more sophisticated multi-objective approaches. Only recently, the focus has shifted towards effective ways of exploiting the mounting information provided by the availability of many sets of concurrent rainfall and flow measurements. This paper revisits through a case study the transition just elucidated: the calibration of a SWMM model applied to a catchment in Singapore is tackled through a single-objective, a multi-objective and a multi-objective multiple-event (MOME) paradigm respectively. A new approach to support the latter is presented herein. It consists in formulating the problem of model calibration as a multi-objective problem with m x r objective functions, where m and r are the number of performance criteria and rainfall events respectively, that must be optimized simultaneously. Results suggest that the new MOME framework performs significantly better than the others tested on the case study presented.


Subject(s)
Algorithms , Cities , Models, Theoretical , Rain , Water , Calibration , Models, Genetic , Singapore , Water Movements
12.
Water Sci Technol ; 52(5): 43-52, 2005.
Article in English | MEDLINE | ID: mdl-16248179

ABSTRACT

In order to successfully calibrate an urban drainage model, multiple calibration criteria should be considered. This raises the issue of adopting a method for comparing different solutions (parameter sets) according to a set of objectives. Amongst the global optimization techniques that have blossomed in recent years, Multi Objective Genetic Algorithms (MOGA) have proved effective in numerous engineering applications, including sewer network modelling. Most of the techniques rely on the condition of Pareto efficiency to compare different solutions. However, as the number of criteria increases, the ratio of Pareto optimal to feasible solutions increases as well. The pitfalls are twofold: the efficiency of the genetic algorithm search worsens and decision makers are presented with an overwhelming number of equally optimal solutions. This paper proposes a new MOGA, the Preference Ordering Genetic Algorithm, which alleviates the drawbacks of conventional Pareto-based methods. The efficacy of the algorithm is demonstrated on the calibration of a physically-based, distributed sewer network model and the results are compared with those obtained by NSGA-II, a widely used MOGA.


Subject(s)
Sewage , Waste Disposal, Fluid , Water Movements , Algorithms , Automation , Calibration , Cities
13.
Fitoterapia ; 76(5): 401-11, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15949903

ABSTRACT

Polinacea is a new standardized hydroethanolic extract obtained from Echinacea angustifolia roots containing echinacoside (>4%), the high molecular weight polysaccharide IDN 5405 (>5%) and a isobutylamide fraction (<0.1%). For in vitro tests, a bacterial lipopolysaccharide-free (LPS-free) Polinacea has been prepared in order to avoid non-specific responses of immunocompetent cells. LPS-free Polinacea enhanced the immune functions as highlighted by the proliferation rate and gamma-interferon production in murine T-lymphocyte cell cultures stimulated by anti-CD3. LPS-free Polinacea did not have a direct role on macrophage response as measured in the nitric oxide production test using the J774 macrophage cells line. In vivo, Polinacea showed an immune stimulating activity by reducing the Candida albicans induced mortality both in normal and in cyclosporin A-treated mice.


Subject(s)
Echinacea , Macrophages/drug effects , Phytotherapy , Plant Extracts/pharmacology , T-Lymphocytes/drug effects , Animals , Candida albicans/immunology , Candida albicans/pathogenicity , Cells, Cultured , Female , Interferon-gamma/biosynthesis , Lipopolysaccharides , Macrophage Activation/drug effects , Macrophages/metabolism , Mice , Mice, Inbred BALB C , Nitric Oxide/biosynthesis , Plant Extracts/administration & dosage , Plant Extracts/therapeutic use , Plant Roots , T-Lymphocytes/immunology
14.
Nature ; 435(7040): 313-6, 2005 May 19.
Article in English | MEDLINE | ID: mdl-15902250

ABSTRACT

The nature of ultrahigh-energy cosmic rays (UHECRs) at energies >10(20) eV remains a mystery. They are likely to be of extragalactic origin, but should be absorbed within approximately 50 Mpc through interactions with the cosmic microwave background. As there are no sufficiently powerful accelerators within this distance from the Galaxy, explanations for UHECRs range from unusual astrophysical sources to exotic string physics. Also unclear is whether UHECRs consist of protons, heavy nuclei, neutrinos or gamma-rays. To resolve these questions, larger detectors with higher duty cycles and which combine multiple detection techniques are needed. Radio emission from UHECRs, on the other hand, is unaffected by attenuation, has a high duty cycle, gives calorimetric measurements and provides high directional accuracy. Here we report the detection of radio flashes from cosmic-ray air showers using low-cost digital radio receivers. We show that the radiation can be understood in terms of the geosynchrotron effect. Our results show that it should be possible to determine the nature and composition of UHECRs with combined radio and particle detectors, and to detect the ultrahigh-energy neutrinos expected from flavour mixing.

15.
Fitoterapia ; 71 Suppl 1: S21-8, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10930709

ABSTRACT

The prostate, after the age of 45 years, may undergo benign hyperplasia (BPH). Its etiology has not yet been completely explained, but different factors play a major role in its occurrence, among them, the sexual hormones (with a fundamental role of 5 alpha reductase). The 5-alpha reductase activity and inflammatory aspects in the prostate tissue can be effectively controlled with the use of highly standardized plant extracts (Pygeum africanum, Serenoa repens, etc.), which yield excellent results in the prophylaxis and treatment of the symptoms linked to prostate hypertrophy. The prostate tissue is not affected only by benign diseases but may also be subject to neoplastic transformation. From an epidemiological point of view, a vegetable derivative, lycopene, was linked with a lower occurrence of prostate carcinoma. A recent clinical study demonstrated that lycopene might not only prevent prostate cancer but also have therapeutic effects.


Subject(s)
Antineoplastic Agents, Phytogenic/therapeutic use , Phytotherapy , Plant Extracts/therapeutic use , Prostatic Hyperplasia/drug therapy , Prunus africana , Serenoa , Animals , Carotenoids/therapeutic use , Humans , Lycopene , Male , Rats
16.
J Med Chem ; 40(13): 2011-6, 1997 Jun 20.
Article in English | MEDLINE | ID: mdl-9207942

ABSTRACT

Leflunomide is one of the most promising disease-modifying antirheumatic drug now in clinical trials for the treatment of rheumatoid arthritis. Metabolic studies have indicated that leflunomide is rapidly processed in vivo to an active metabolite, A771726 (2). To identify the chemical characteristics necessary for the immunosuppressive activity of 2, configurational and conformational studies were carried out on the latter and its inactive analogues (ethyl 3-hydroxy-2-((4-(trifluoromethyl)phenyl)carbamoyl)but-2-enoate, 3a, and 3-hydroxy-2-nitro-N-(4-(trifluoromethyl)phenyl)but-2-enamide, 3b). These studies suggested that the pharmacophore responsible for the immunosuppressive activity of 2 is a beta-keto amide with the enolic hydroxy group cis to the amidic moiety. To verify this hypothesis, a new class of immunosuppressive agents was designed and synthesized. Their testing in vitro and in vivo identified compounds which were more potent than both leflunomide and 2 and above all confirmed our hypothesis as to the key structural and chemical determinants for the immunosuppressive properties of 2 and our compounds.


Subject(s)
Immunosuppressive Agents/metabolism , Isoxazoles/metabolism , Aniline Compounds/metabolism , Animals , Crotonates , Female , Hydroxybutyrates/metabolism , Immunosuppressive Agents/chemistry , Isoxazoles/chemistry , Leflunomide , Lymphocyte Culture Test, Mixed , Mice , Mice, Inbred BALB C , Nitriles , Prodrugs/chemistry , Prodrugs/metabolism , Structure-Activity Relationship , Toluidines
17.
J Pharmacol Toxicol Methods ; 37(2): 91-6, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9174984

ABSTRACT

Administration of antigen suspended in incomplete Freund's adjuvant supplemented with either heat-killed Mycobacterium tuberculosis (complete Freund's adjuvant, CFA) or Bordetella pertussis toxin sensitizes animals so that subsequent antigen challenge leads to delayed-type (DTH) or immediate type hypersensitivity (ITH) responses, named type IV and type I, respectively. Appropriate timing of administration of drugs with respect to immunization or antigen challenge allowed to detect predominantly immunosuppressive, antiinflammatory or antianaphylactic activities. Among the reference drugs tested, only cyclosporin A (CsA) and dexamethasone (Dex) markedly inhibited DTH reaction, due to their immunosuppressive and antiinflammatory activities, respectively, whereas leflunomide and indomethacin resulted less potent. On the other hand, only dexchlorpheniramine, a histamine-receptor antagonist, afforded significant protection against anaphylactic shock, a form of ITH. Two new chemical entities were studied according to this protocol: ITF 1697, a chemically stabilized C-reactive protein-derived tetrapeptide, and ITF 2018, a leflunomide analogue. Data obtained with these new compounds showed that ITF 1697 has antianaphylactic activity, while ITF 2018 is endowed, mainly, with antiinflammatory activity. These results show that, through appropriate timing of administration, established in vivo models of immunologically mediated disease states allow an accurate profiling of the effects of pharmacologically active molecules and the detection of unsuspected activities for new drugs.


Subject(s)
Drug Evaluation, Preclinical/methods , Immunosuppressive Agents/immunology , Animals , C-Reactive Protein/analogs & derivatives , Cyclosporine/immunology , Cyclosporine/pharmacology , Female , Hypersensitivity, Delayed , Hypersensitivity, Immediate , Immunosuppressive Agents/pharmacology , Indomethacin/immunology , Indomethacin/pharmacology , Isoxazoles/chemistry , Isoxazoles/immunology , Isoxazoles/pharmacology , Leflunomide , Mice , Mice, Inbred BALB C
18.
Clin Exp Immunol ; 103(3): 384-90, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8608635

ABSTRACT

The heat shock protein, hsp10, is an abundant protein in Mycobacterium tuberculosis (Mtb), its nucleotide sequence encoding a protein of 99 amino acids with a molecular mass of 10.7 kD. This sequence is phylogenetically conserved, being represented by the GroES homologue of Escherichia coli. Hsp10 and GroES are members of the chaperonin 10 family of molecular chaperones, and GroEs is necessary for the optimal activity of GroEL, a member of the chaperonin 60 family and the E. coli homologue of mycobacterial hsp65. Since hsp65 has been implicated in both experimental and human rheumatoid arthritis, we aimed to assess the immunomodulatory effects of its co-chaperonin, hsp10, in experimental arthritis. Our results show that an aqueous solution of a mycobacterial hsp10 delayed the onset and severity of adjuvant-induced arthritis in rodents when administered after disease induction but before joint involvement occurred. This biological activity was specific for the hsp10 of Mtb, since neither GroES not the rat homologue was effective. Using synthetic hsp10 fragments, the activity was localized to the N-terminal region of the molecule. Assessment of circulating antibody levels to mycobacterial hsp10 and hsp65 indicated that all arthritic rats had increased titres to both hsp10 and hsp65: hsp10-treated rats showed further elevation of this humoral response not only to hsp10 but also to hsp65 when compared with the untreated arthritic control. This is the first report of the immunomodulatory activity of mycobacterial hsp10 in experimental arthritis, and exhibits a potential role for this co-chaperonin in pathophysiological situations.


Subject(s)
Arthritis, Experimental/drug therapy , Bacterial Proteins/immunology , Bacterial Proteins/pharmacology , Chaperonin 10/immunology , Chaperonin 10/pharmacology , Mycobacterium tuberculosis/metabolism , Adjuvants, Immunologic/pharmacology , Animals , Arthritis, Experimental/immunology , Female , Peptide Fragments/immunology , Peptide Fragments/pharmacology , Rats , Rats, Inbred Lew , Rats, Wistar , Sensitivity and Specificity
19.
J Immunol ; 155(6): 3112-23, 1995 Sep 15.
Article in English | MEDLINE | ID: mdl-7673726

ABSTRACT

The cDNA coding for mouse IL-10 (mIL-10) was transduced into the parental cells of a spontaneous adenocarcinoma of BALB/c mice (TSA-pc), and clones secreting small, medium, and large quantities of IL-10 were selected. In vivo, both low and high producer clones do not display an enhanced ability to grow in H-2 and non-H-2 incompatible mice. Instead, the intensity of their rejection increases in function of the amount of mIL-10 released. After an initial growth period in syngeneic mice, high producer clones undergo complete rejection due to the combined action of CD8+ lymphocytes, NK cells, and neutrophils. After this rejection, mice are immune to a subsequent challenge with TSA-pc. This memory rests on a strong lytic activity of CD8+ CTL and granulocytes. Following the rejection, mice also develop anti-TSA Ab that guide the granulocytes in TSA-pc memory reaction. A direct comparison shows that although TSA clones engineered to release IL-2 activate CTL and no anti-TSA Ab, those engineered to release IL-4 activate a strong Ab response but not CTL. The kind of cytokine released by the tumors appears to determine the type of response. However, IL-10 high producer cells do not deviate the immune memory, neither toward a Th1 nor a Th2. Both the CTL activity and the Ab responses induced by IL-10 high producer cells are the strongest so far observed in the TSA system.


Subject(s)
Adenocarcinoma/immunology , CD8-Positive T-Lymphocytes/immunology , Immunologic Memory , Interleukin-10/metabolism , Mammary Neoplasms, Experimental/immunology , Adenocarcinoma/pathology , Adenocarcinoma/ultrastructure , Animals , Base Sequence , Cytotoxicity, Immunologic , Female , Gene Transfer Techniques , Interleukin-10/genetics , Interleukin-10/pharmacology , Lymphocyte Activation/drug effects , Mammary Neoplasms, Experimental/pathology , Mammary Neoplasms, Experimental/ultrastructure , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Microscopy, Electron , Molecular Sequence Data , Tumor Cells, Cultured
20.
J Immunol ; 153(12): 5659-73, 1994 Dec 15.
Article in English | MEDLINE | ID: mdl-7989764

ABSTRACT

A retroviral infection was used to introduce the cDNA coding for mouse IL-4 into the parental cells of a spontaneous adenocarcinoma of BALB/c mice (TS/A-pc). Four clones releasing between 5 to 40 U of IL-4 (10(5) cells) in 48 h culture were selected. The secretion of IL-4 does not affect their in vitro growth, whereas their ability to form tumor in vivo inversely correlates with the amount of IL-4 secreted. Although morphologic observation suggested that the rejection of clone D5.40 cells (releasing 40 U of IL-4) depends on eosinophil cytolysis, lymphocyte depletion experiments showed that this required CD8+ lymphocyte guidance. Mice that had rejected D5.40 cells were immune to a subsequent challenge with TS/A-pc. This memory rests on the interaction between noncytotoxic lymphocytes, eosinophils, and IgG1 and IgE anti-TS/A Abs. Comparison of these memory mechanisms with those elicited by IL-2 gene-transduced TS/A cells shows that the kind of cytokine released by the tumor cells determines the type of response. This Th2 memory seems to be more efficient in protecting against a subsequent challenge of TS/A-pc than the Th1-type memory elicited by IL-2 gene-transduced TS/A cells.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Eosinophils/immunology , Interleukin-4/biosynthesis , Mammary Neoplasms, Experimental/immunology , Th2 Cells/immunology , Adenocarcinoma/immunology , Animals , Antibody-Dependent Cell Cytotoxicity/immunology , Female , Flow Cytometry , Immunoglobulin Class Switching/immunology , Immunotherapy, Adoptive , Mammary Neoplasms, Experimental/pathology , Mammary Neoplasms, Experimental/ultrastructure , Mice , Mice, Inbred BALB C , Neoplasm Transplantation/immunology , Transfection/immunology , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...